Nascent Biotech Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nascent Biotech Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Nascent Biotech Inc. Return On Equity for the quarter ending June 30, 2024 was 1.03K %, a 526% increase year-over-year.
  • Nascent Biotech Inc. annual Return On Equity for 2023 was 158 %, a 57.7% decline from 2022.
  • Nascent Biotech Inc. annual Return On Equity for 2022 was 374 %, a 677% increase from 2021.
  • Nascent Biotech Inc. annual Return On Equity for 2021 was 48.1 %, a 34.2% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 158 -216 -57.7% Apr 1, 2023 Mar 31, 2024
2022 374 +325 +677% Apr 1, 2022 Mar 31, 2023
2021 48.1 -25 -34.2% Apr 1, 2021 Mar 31, 2022
2020 73.1 -871 -92.3% Apr 1, 2020 Mar 31, 2021
2019 944 +1.17K Apr 1, 2019 Mar 31, 2020
2018 -225 +254 +53% Apr 1, 2018 Mar 31, 2019
2017 -479 -397 -487% Apr 1, 2017 Mar 31, 2018
2016 -81.6 Apr 1, 2016 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.